Industry finds voice to rebut NGO against Indian pricing policy
This article was originally published in Scrip
Executive Summary
India's draft national pharmaceutical pricing policy faces legal challenges with a leading NGO opposing the crux of the new pricing approach, and large multinationals under the ambit of the Organisation of Pharmaceutical Producers of India (OPPI) seeking to be heard in the case to defend their interests.